• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科癌症协作组在提高卵巢癌临床试验水平方面的全球影响。

The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.

机构信息

Queen's University, Kingston, Ontario, Canada.

出版信息

Int J Gynecol Cancer. 2011 May;21(4):746-9. doi: 10.1097/IGC.0b013e31821bb446.

DOI:10.1097/IGC.0b013e31821bb446
PMID:21543935
Abstract

The Gynecologic Cancer InterGroup (GCIG) has developed from a small network of ovarian cancer researchers to a large international forum addressing multiple issues related to research in gynecologic cancers. Member groups of the GCIG have collaboratively conducted pivotal clinical trials in cancers of the ovary, endometrium, and cervix. The participation of operational and statistical personnel from the GCIG member groups has facilitated a collegial approach to international differences and restrictions.One of the powerful initiatives of the GCIG is the facilitation of the Ovarian Cancer Consensus Conference every few years. The 4th Ovarian Cancer Consensus Conference was held in Vancouver, Canada, in June 2010, and the resulting publications (herein) provide an invaluable resource to researchers in the field of gynecologic oncology.

摘要

妇科癌症国际协作组(GCIG)已由一个小型卵巢癌研究人员网络发展成为一个大型国际论坛,致力于解决妇科癌症研究的多个问题。GCIG 的成员团体合作开展了卵巢癌、子宫内膜癌和宫颈癌的关键临床试验。GCIG 成员团体的运营和统计人员的参与促进了国际差异和限制的协作方法。GCIG 的一项强大举措是每隔几年促进卵巢癌共识会议。第四次卵巢癌共识会议于 2010 年 6 月在加拿大温哥华举行,由此产生的出版物(本文)为妇科肿瘤学领域的研究人员提供了宝贵的资源。

相似文献

1
The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.妇科癌症协作组在提高卵巢癌临床试验水平方面的全球影响。
Int J Gynecol Cancer. 2011 May;21(4):746-9. doi: 10.1097/IGC.0b013e31821bb446.
2
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.2010 年妇科癌症国际协作组(GCIG)卵巢癌临床试验共识声明:第四届卵巢癌共识会议报告。
Int J Gynecol Cancer. 2011 May;21(4):750-5. doi: 10.1097/IGC.0b013e31821b2568.
3
American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.美国临床肿瘤学会 2012 年年会:妇科肿瘤学专场亮点。
Int J Gynecol Cancer. 2012 Nov;22(9):1634-9. doi: 10.1097/IGC.0b013e318270febe.
4
Clinical trials in recurrent ovarian cancer.复发性卵巢癌的临床试验。
Int J Gynecol Cancer. 2011 May;21(4):771-5. doi: 10.1097/IGC.0b013e31821bb8aa.
5
First-line therapy in ovarian cancer trials.卵巢癌临床试验中的一线治疗。
Int J Gynecol Cancer. 2011 May;21(4):756-62. doi: 10.1097/IGC.0b013e31821ce75d.
6
Strategies and goals: the future of the International Gynecologic Cancer Society: IGCS Presidential Address.策略与目标:国际妇科癌症协会的未来:国际妇科癌症协会主席致辞
Int J Gynecol Cancer. 2010 Dec;20(9):1434-9. doi: 10.1097/IGC.0b013e318202df07.
7
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).妇科肿瘤研究组(GCIG)关于低恶性潜能卵巢肿瘤(交界性卵巢肿瘤)的共识综述。
Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S5-8. doi: 10.1097/IGC.0000000000000282.
8
Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.妇科肿瘤协作组(GCIG)共识综述:子宫和卵巢平滑肌肉瘤
Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S61-6. doi: 10.1097/IGC.0000000000000261.
9
The Gynecologic Cancer Intergroup (GCIG): history and current status.
Ann Oncol. 2005;16 Suppl 8:viii39-viii42. doi: 10.1093/annonc/mdi966.
10
Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference.妇科癌症协作组内的临床试验协调:第五届卵巢癌共识会议的共识和未满足需求。
Ann Oncol. 2017 Nov 1;28(suppl_8):viii30-viii35. doi: 10.1093/annonc/mdx449.